Suppr超能文献

相似文献

1
Sex differences of urinary and kidney globotriaosylceramide and lyso-globotriaosylceramide in Fabry mice.
J Lipid Res. 2011 Sep;52(9):1742-6. doi: 10.1194/jlr.M017178. Epub 2011 Jul 11.
3
Urinary biomarker investigation in children with Fabry disease using tandem mass spectrometry.
Clin Chim Acta. 2015 Jan 1;438:195-204. doi: 10.1016/j.cca.2014.08.002. Epub 2014 Aug 19.
4
Multiplex analysis of novel urinary lyso-Gb3-related biomarkers for Fabry disease by tandem mass spectrometry.
Anal Chem. 2013 Feb 5;85(3):1743-52. doi: 10.1021/ac303033v. Epub 2013 Jan 7.
5
Variations in the GLA gene correlate with globotriaosylceramide and globotriaosylsphingosine analog levels in urine and plasma.
Clin Chim Acta. 2015 Jul 20;447:96-104. doi: 10.1016/j.cca.2015.06.003. Epub 2015 Jun 9.
7
Tandem mass spectrometry multiplex analysis of methylated and non-methylated urinary Gb3 isoforms in Fabry disease patients.
Clin Chim Acta. 2016 Jan 15;452:191-8. doi: 10.1016/j.cca.2015.11.018. Epub 2015 Nov 22.
8
Global glycosphingolipid analysis in urine and plasma of female Fabry disease patients.
Biochim Biophys Acta Mol Basis Dis. 2019 Oct 1;1865(10):2726-2735. doi: 10.1016/j.bbadis.2019.07.005. Epub 2019 Jul 15.
9
A comprehensive testing algorithm for the diagnosis of Fabry disease in males and females.
Mol Genet Metab. 2020 Jul;130(3):209-214. doi: 10.1016/j.ymgme.2020.04.006. Epub 2020 May 3.
10
Risk of death in heart disease is associated with elevated urinary globotriaosylceramide.
J Am Heart Assoc. 2014 Feb 4;3(1):e000394. doi: 10.1161/JAHA.113.000394.

引用本文的文献

1
Systematic gene therapy derived from an investigative study of AAV2/8 vector gene therapy for Fabry disease.
Orphanet J Rare Dis. 2023 Sep 5;18(1):275. doi: 10.1186/s13023-023-02894-0.
2
Optimizing human α-galactosidase for treatment of Fabry disease.
Sci Rep. 2023 Mar 23;13(1):4748. doi: 10.1038/s41598-023-31777-4.
3
A universal GlycoDesign for lysosomal replacement enzymes to improve circulation time and biodistribution.
Front Bioeng Biotechnol. 2023 Feb 24;11:1128371. doi: 10.3389/fbioe.2023.1128371. eCollection 2023.
4
Reduced α-galactosidase A activity in zebrafish ( mirrors distinct features of Fabry nephropathy phenotype.
Mol Genet Metab Rep. 2022 Feb 17;31:100851. doi: 10.1016/j.ymgmr.2022.100851. eCollection 2022 Jun.
5
Assessing the role of glycosphingolipids in the phenotype severity of Fabry disease mouse model.
J Lipid Res. 2020 Nov;61(11):1410-1423. doi: 10.1194/jlr.RA120000909. Epub 2020 Aug 31.
6
Genetic, dietary, and sex-specific regulation of hepatic ceramides and the relationship between hepatic ceramides and IR.
J Lipid Res. 2018 Jul;59(7):1164-1174. doi: 10.1194/jlr.M081398. Epub 2018 May 8.
7
Glycosphingolipid storage in Fabry mice extends beyond globotriaosylceramide and is affected by ABCB1 depletion.
Future Sci OA. 2016 Oct 13;2(4):FSO147. doi: 10.4155/fsoa-2016-0027. eCollection 2016 Dec.
9
Mannose receptor-mediated delivery of moss-made α-galactosidase A efficiently corrects enzyme deficiency in Fabry mice.
J Inherit Metab Dis. 2016 Mar;39(2):293-303. doi: 10.1007/s10545-015-9886-9. Epub 2015 Aug 27.
10
Interfering parameters in the determination of urinary globotriaosylceramide (Gb3) in patients with chronic kidney disease.
J Nephrol. 2015 Dec;28(6):679-89. doi: 10.1007/s40620-015-0193-1. Epub 2015 Apr 10.

本文引用的文献

1
Substrate reduction augments the efficacy of enzyme therapy in a mouse model of Fabry disease.
PLoS One. 2010 Nov 24;5(11):e15033. doi: 10.1371/journal.pone.0015033.
3
How well does urinary lyso-Gb3 function as a biomarker in Fabry disease?
Clin Chim Acta. 2010 Dec 14;411(23-24):1906-14. doi: 10.1016/j.cca.2010.07.038. Epub 2010 Aug 14.
6
Fabry disease.
Pharmacol Ther. 2009 Apr;122(1):65-77. doi: 10.1016/j.pharmthera.2009.01.003. Epub 2009 Feb 8.
8
Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells.
Mol Genet Metab. 2008 Nov;95(3):163-8. doi: 10.1016/j.ymgme.2008.06.016. Epub 2008 Aug 15.
9
Elevated globotriaosylsphingosine is a hallmark of Fabry disease.
Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2812-7. doi: 10.1073/pnas.0712309105. Epub 2008 Feb 19.
10
Urinary globotriaosylceramide excretion correlates with the genotype in children and adults with Fabry disease.
Mol Genet Metab. 2008 Mar;93(3):331-40. doi: 10.1016/j.ymgme.2007.10.001. Epub 2007 Nov 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验